Purchase Order W81K0020P0251
Award Date 10/1/20
Potential Completion Date 9/30/24
Potential Value $588K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Antonio, TX 78234, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a sole source contract awarded by the Department of the Army Medical Command to Lantheus Medical Imaging, Inc. for the supply of Definity, an injectable cardiovascular ultrasound contrast agent. The contract has a value of $208,402.20 and a completion date of September 30, 2019. Lantheus Medical Imaging is a manufacturer of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The contract was awarded...
- Lantheus Medical Imaging, Inc. was awarded a $96,748.26 firm fixed price call against the Defense Health Agency's UC 180 Radiopharmaceuticals blanket purchase agreement to provide radiopharmaceutical products and services. As the prime contractor, Lantheus Medical Imaging will deliver the requested supplies from its production facility in Fort Sam Houston, Texas by September 11, 2023 in support of the Defense Health Agency's medical imaging programs. No subcontractors or set aside designations...
- This is a $375,785.71 fixed-price with economic price adjustment purchase order contract awarded to Lantheus Medical Imaging, Inc. by the Defense Health Agency (DHA) for the procurement of radiopharmaceutical diagnostic products. The contract is set aside for small businesses and has an ultimate completion date of December 31, 2014. Lantheus Medical Imaging, a for-profit manufacturer of diagnostic medical imaging agents and products, is the prime contractor. The contract is part of a larger...
- This is a firm fixed price purchase order contract awarded by the Department of the Army Medical Command to Lantheus Medical Imaging, Inc. for the provision of radiopharmaceuticals. The contract is valued at $141,137.33 and has a completion date of September 30, 2019. The contract was awarded on June 29, 2018 and is not set-aside. Lantheus Medical Imaging, a manufacturer of diagnostic medical imaging agents and products, is providing technetium-99m generators, xenon-133 gas, sestamibi vials, and...
- This federal contract award W91YU016P0082 was issued by the Medical Command (MEDCOM) of the U.S. Army to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and radiopharmaceutical products. The $241,498.00 firm fixed-price purchase order is for the delivery of radiopharmaceuticals, which are critical medical supplies used in diagnostic procedures at military treatment facilities and VA medical centers. The contract is a small business set-aside award...
- The Defense Health Agency awarded a $66,256.48 firm fixed price blanket purchase agreement call contract to Lantheus Medical Imaging, Inc. for the delivery of radiopharmaceuticals. As the parent company, Lantheus Holdings, Inc. oversees performance of this contract. No set-aside provisions were specified in the award. Lantheus Medical Imaging will provide the radiopharmaceutical products to the Defense Health Agency from its place of performance in Fort Sam Houston, Texas, in support of the...
- The Defense Health Agency awarded a $63,681.93 firm fixed-price purchase order to Lantheus Medical Imaging, Inc. for the supply of Technetium-99m generators and Xenon radiopharmaceuticals, with performance in San Antonio, TX and completion by December 31, 2025. This contract was awarded without a small business set-aside designation. Lantheus Medical Imaging, a subsidiary of Lantheus Holdings, Inc., is a manufacturer of diagnostic medical imaging agents and radiopharmaceutical products based...
- This federal contract award is for the delivery of medical imaging products for nuclear medicine use at the Walter Reed National Military Medical Center. The prime contractor is Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and products. The contract was awarded by the Defense Health Agency on a firm fixed price basis using Lantheus' Pharmaceuticals and Drugs Schedule contract. The potential value of the delivery order is $149,558.58, and it has a...
- This federal contract award, valued at $250,000.00, was issued by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and radiopharmaceutical products. The contract covers the provision of various radiopharmaceuticals, with a period of performance through September 30, 2024. This award is part of a larger Blanket Purchase Agreement (BPA) that Lantheus Medical Imaging holds with the DHA, valued at $6.5 million and...
- Lantheus Medical Imaging, Inc. has been awarded a blanket purchase agreement call by the Defense Health Agency to provide radiopharmaceuticals and supplies. The single-award BPA, with a potential value of $100,000, enables the agency to acquire standardized radiotracers, technetium-99m generators, and other nuclear medicine products through September 2023 for use at military treatment facilities. Delivery will be to locations in El Paso, Texas. Pricing is set at firm fixed price. As the prime...